Skip to main content
ANTEROGEN CO., LTD. logo

ANTEROGEN CO., LTD. — Investor Relations & Filings

Ticker · 065660 ISIN · KR7065660003 KO Manufacturing
Open in API
Filings indexed 267 across all filing types
Latest filing 2021-12-17 M&A Activity
Country KR South Korea
Listing KO 065660

About ANTEROGEN CO., LTD.

http://anterogen.com

ANTEROGEN CO., LTD. is a bio-venture company engaged in the research, development, and commercialization of cell therapy products and orphan drugs. The company specializes in utilizing adult stem cells, particularly adipose-derived mesenchymal stem cells, to create innovative treatments. Its key commercialized products include Cupistem®, an autologous stem cell therapy for Crohn's fistula, and Queencell®. Anterogen's research pipeline extends to applications for musculoskeletal diseases, spinal injuries, and cardiovascular conditions. The company also offers stem cell banking services.

Recent filings

Filing Released Lang Actions
주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding a merger decision (회사합병 결정) between Anterogen Co., Ltd. and CSK Co., Ltd. It details the merger ratio, background, financial impact, and legal compliance. This falls under the category of M&A activity (mergers and acquisitions).
2021-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice from Antrogen regarding the setting of a record date and shareholder register closure period for the purpose of a small-scale merger. It does not contain the full merger agreement or financial statements, but rather serves as a formal regulatory notification of a corporate action. As it does not fit into specific categories like M&A (TAR) or Dividend (DIV), and is a standard regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2021-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the meeting preparation. Given the nature of the announcement as a regulatory disclosure, it fits best under the RNS category.
2021-12-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an official announcement regarding the scheduling and logistics of an Investor Relations (IR) meeting (기업설명회). It provides the date, time, location (online), purpose, and registration details for the event. Since it is an announcement of an upcoming presentation rather than the presentation slides themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a formal corporate disclosure of an event.
2021-11-23 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '안트로젠' (Anterogen) covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial information, business operations, management discussion, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean
기타경영사항(자율공시)(범부처재생의료기술개발사업 연구과제 선정)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) by Antrogen regarding the selection of a research project for a government-funded regenerative medicine development program. It details the project title, scope, funding, and timeline. Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a standard regulatory announcement of a corporate development, it falls under the general regulatory filing category.
2021-09-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.